← Back to headlines
Cogent Biosciences Prepares for Bezuclastinib Launch Awaiting FDA Approval
Cogent Biosciences Inc. is gearing up for the launch of its drug Bezuclastinib, pending final approval from the FDA.
2 Mar, 07:57 — 2 Mar, 07:57
Sources
Showing 1 of 1 sources
Related Stories
UST students pay tribute to 'silent teachers' in interment ceremony
just now
UST Medical Students Pay Tribute to 'Silent Teachers' Laid to Rest
just now
Visayas Braces for Intensifying Heat as Heat Index Nears Danger Levels
just now
Latvian Government Merges Five Psychiatric Hospitals into National Center
just now